Enterprise Capital Fund
Oxford Technology ECF is a £30 million specialist technology fund. The fund is structured as a Limited Partnership, with the UK government through the Department for Business, Enterprise and Regulatory Reform ("BERR") as the largest investor and Limited Partner. Other Limited Partners include institutional and individual investors, and the directors of Oxford Technology Management Limited.
Acunu Limited is developing software to manage data storage. Acunu's software is designed to optimise the performance of storage by moving data dynamically according to usage. Less actively used data can be stored efficiently in disks that are not spinning, and which therefore use much less energy but take longer to access. More actively stored data can be striped across disks to optimise performance. With the emergence of Big Data, the nature of data and its access requirements has changed, but the technology has not yet. This is creating an opportunity for new optimisation approaches. Acunu's software manages storage at a very low level in the storage stack, and can be combined with other emerging technologies for improving data storage. The first and probably most important target market is so‐called Big Data, the storage of large amounts of data relating to transaction or usage patterns. For the first product, Acunu sits underneath Cassandra, an open‐source Big Data standard based on Facebook's storage architecture.Last Updated: Friday, September 09, 2011
In a recovery ward in a modern hospital, every major bodily function is now monitored by machine except for breathing rate. This is still done by a nurse with a stopwatch, however, nurses are busy and can only monitor breathing periodically. But breathing rate is actually the most important function to monitor since it is this which in most cases gives the earliest indication of problems. Blood oxygen level is automatically monitored but if a patient stops breathing, their blood oxygen level will not change for a period of maybe a minute, and by this time damage to other organs may already have started. Founded in 2002, Anaxsys obtained a CE mark for Respir8, its breathing monitor, in September 2010. The product is sold for £800 (+ £8/use for the disposable) and attached to a patient and displays the breathing rate as a single number (eg 26 – meaning 26 breaths/minute) in very large figures which may be read at a distance. The product is also alarmed and if the breathing rate falls below a limit (which may be set) or rises above a certain limit, a loud alarm will be sounded.Last Updated: Friday, September 09, 2011
Azellon is developing an autologous stem cell based treatment for meniscal damage, the cartilage that provides 'shock absorption' for the knee joint.Last Updated: Friday, September 09, 2011
Base4 is developing a novel solid state, single molecule detection device with applications in ultra high speed DNA sequencing, gene expression analysis, and diagnostics.Last Updated: Friday, September 09, 2011
Tyre companies produce a waste product which is a mixture of steel wire and rubber. In the past, most of this waste was either incinerated at very high temperature or went to landfill. Cleansteel has developed a process, and subsequently established a plant in Slough to treat this waste. The waste is separated into its two component parts, both of which are valuable and may then be reused.Last Updated: Monday, January 14, 2013
Cobalt has developed a rapid assay instrument for Pharmaceutical dosage forms, using novel techniques invented by Prof. Pavel Matousek of the Rutherford Appleton Laboratories. These instruments are useful for pharmaceutical companies because they provide a highly specific, non-invasive, non-destructive compositional assay of tablets or capsules in less than a second the speed of the assay enables Pharma companies to assay in real time on the production line, the specific nature of the assay enables customers to create, update and transfer methods more easily and the non-invasive aspect enables customers to simply test tablets or capsule or dosage forms through brown glass or plastic containers without any sample preparation work. The company has conducted a wide range of tests with leading Pharmaceutical companies including Pfizer and Astra Zeneca, and has published several papers on some of these studies.
The technology is described in a family of patent filings held by STFC (Science & Technology Facilities Council), part of the UK Government. Lite Thru is an exclusive licensee of the patent filings and was spun out to commercialise the technology. Lite Thru is backed by Oxford Technology ECF and the Rainbow Seed Fund.Last Updated: Tuesday, October 04, 2011
Crysalin is developing a three dimensional, 'self‐assembling' protein scaffold which may be used to impose a uniform and regular 'crystalline‐like' structure on novel proteins which would otherwise be difficult or impossible to crystallise. This scaffold would render a huge number of such 'hard to crystallise' proteins amenable to high‐resolution structural elucidation by X‐ray crystallography. Such proteins are often highly valuable potential drug development targets and drug development companies pay high prices for high‐resolution structural information on these targets.Last Updated: Friday, September 09, 2011
Designed Materials ('DML') was founded to develop and commercialise a new process formaking synthetic diamond invented by Dr. Phil Taylor and Prof. Marshall Stoneham (bothfrom UCL). The same technology can potentially also be used to anneal natural or syntheticdiamond to alter their properties such as their colour or clarity.Last Updated: Tuesday, October 04, 2011
Diamond Microwave Devices ('DMD') spun out of Element Six's research labs in Ascot and is developing a high power microwave amplifier and a diamond transistor that could enable the amplifier to operate at unusually high power/high frequency. This diamond transistor, if it works, would provide a critical breakthrough capability in defence applications such as seeker missiles, electronic warfare and satellite communications.Last Updated: Friday, September 09, 2011
Historic Futures ('HF') provides retailers and their suppliers with a platform to record and trace information about the provenance of products. Oxford Technology 4 VCT has been an investor since July 2005. Historic Futures has developed a system called String to enable companies to share data about the products they manufacture with their customers further down the supply chain, and ultimately the retailer and consumer – to enable supply chain traceability. It is particularly useful for products that have multiple sequential players in the supply chain, for example, natural fibres like cotton or wool. However, the system is product agnostic and can be used to track any attributes (carbon, energy, chemicals, water) used during manufacture.Last Updated: Friday, September 09, 2011
Ibexis has developed a low cost, low power data logger which be installed anywhere transmits data from up to 75 different sensors back to base where it can be displayed on a website. It uses either the mobile phone network or a satellite. For example, one Ibexis datalogger floats on a lake in Greece, powered by a small solar panel and sends information about water temperature and quality every 15 minutes.
Example uses so far include:
1. Monitoring water salinity/temp from lakes in Greece.
2. Monitoring the use of Ice-vending machines in the US.
3. Monitoring the level of fuel for trains in transport depots in the UK.
4. Monitoring water levels in boreholes in Norway and Sweden.
5. Monitoring power consumption in industrial motors in Germany.
6. Monitoring buildings for fire in Middle East.
7. Monitoring water run-off from an airport.
8. Real time monitoring of fuel consumption in trucks.
9. Air pollution monitoring in India (c 30 parameters per MSP)Last Updated: Friday, January 11, 2013
Lab Minds was established to design and build a prototype instrument to mix buffer solutions, a routine task on which research chemists spend a large amount of time each year. The prototype was completed in Spring 2011, and patents applied for. Researchers may order their buffer solutions using their mobile phones. The Easysolution machine first cleans the central mixing chamber. Then adds an acid solution to calibrate its pH sensors. Then, after another cleaning cycle a precise volume of deionised water is added. To this is added the precise weight of the various salts needed. After mixing, acid is added and, after a suitable settling time, the pH is measured. More acid or base is then added until the correct pH is reached. The solution is then dispensed into a bottle, and a text message or email sent to the researcher to let them know that their buffer solution is ready for collection.
Apart from convenience, Easysolution offers computer-controlled accuracy and repeatability, and, since no human handling of salts or other chemicals or liquids is required many questions of safety are avoided.
In Dec 2012 Lab Minds signed heads of terms with one of the largest global companies in the field, and the two companies will now work together with the aim of launching a production version in due course.Last Updated: Friday, January 11, 2013
Meciria Ltd has been developing a drill steering tool that if successful, would enable an oilcompany to save as much as 35% of the average $2M cost to drill a land‐based shale gaswell.Last Updated: Tuesday, October 04, 2011
MicroVisk has developed a MEMS (MicroElectroMechanical System) silicon chip based technology that measures fluid viscosity. Its primary product focus is a Point‐of‐Care (POC) and a Patient Self Test (PST) medical device for measuring blood coagulation rate, used particularly for monitoring patients on warfarin therapy. The base technology has other potential high value applications both within medical diagnostics and without.Last Updated: Friday, September 09, 2011
MirriAd Limited has developed software that enables retrospective product placement invideo content. MirriAd's target customers are broadcasters and content producers who wishto sell embedded advertising. OTECF originally invested £874K as part of a £2 millionfundraising by the company in 2008.MirriAd has now developed a suite of products to help broadcasters sell advertising space incontent. MirriAd's software highlights good spots for advertising in the content, measuresthe exposure relative to other spots and allows the customer to evaluate alternative spots.The exposure metrics also help the sales team to agree pricing with their customers.
Last Updated: Tuesday, October 04, 2011
Organox is developing a medical device for the artificial support of human organs awaiting transplantation. It is initially focused on the liver and has a granted patent for an approach which dramatically increases storage times for human livers whilst maintaining them at body temperature (normothermic perfusion) rather than cooling them on ice.Last Updated: Friday, September 09, 2011
Oxis Energy has been developing a high energy density battery principally for E‐Vehicle applications.Last Updated: Friday, September 09, 2011
The objective of phase 1 of Personal Lifting is to build a prototype of a device which will enable a nurse to lift a patient from a hospital bed without any effort on her part and then to move the patient into a sitting position and, if desired to unload him onto a chair. The device, which will not look out of place in a clean hospital environment, will lift a patient in the same manner as a fork-lift truck, but with 18 tines. The clever (and patented) part is that the tines are hollow and covered with an inflatable sleeve which is attached to the outside of the tine and which then goes forward and down the inside of the tine. When air pressure is applied, the tines evert, (in a controlled manner, under the influence of a string which unwinds from a motor-driven wheel) finding its way between the patient and the bed. There is no friction or sliding; each point of the sleeve remains in contact with the first point on the patient which it encounters – the tine everts from the centre, like blowing a rubber glove inside out. At the end the patient is suspended on an air mattress and the metal tines can then be inserted and the patient lifted up and moved into a sitting position if desired. (In practice the tines move in a few centimetres behind the leading edge of the inflating tine – to save time).
By 2012, the prototype was working in the sense that it could acquire a patient from a bed, fold them into a sitting position and deposit them on a chair, all without any physical effort being required from the nurse. However, after a few cycles, the sleeves developed leaks, making the device not useable in practice. The next task is to find a develop a meterial which would be light enough and flexible enough for the task but which would not develop leaks. Additional capital is being raised in order to do this.Last Updated: Monday, January 14, 2013
Radio Tactics Limited designs and sells systems for the extraction of data from mobile phone handsets. Its primary customers are law enforcement and military agencies.Last Updated: Friday, September 09, 2011
VCT 3rd Quarter Results Announced
The Net Asset Values as at 30th November 2012 have been announced as:
OT1 VCT - 95p Dividends to date 42.7p
OT2 VCT - 27p Dividends to date 10.5p
OT3 VCT - 105p Dividends to date 10p
OT4 VCT - 68p Dividends to date 17pWednesday, December 12, 2012
VCT Interim Results Announced
The Net Asset Values as at 31st August 2012 have been announced as:
OT1 VCT - 68p Dividends to date 42.7p
OT2 VCT - 25p Dividends to date 10.5p
OT3 VCT - 91p Dividends to date 10p
OT4 VCT - 67p Dividends to date 17pMonday, October 01, 2012
VCT Annual Financial Results Announced
The Oxford Technology VCTs announce their Annual Results for the year ended 29 February 2012.
OT1 - Net Asset Value 25p - Dividends paid to date 42.7p
OT2 - Net Asset Value 26p - Dividends paid to date 10.5p
OT3 - Net Asset Value 71p - Dividends paid to date 10p
OT4 - Net Asset Value 90p - Dividends paid to date 3p with an additional 14p paid in April 2012Friday, June 01, 2012